GSK shares sink after FDA panel rejects Blenrep cancer drug, raising doubts over turnaround strategy. GSK (LSE: GSK) investors took a sharp knock on Friday after its much-hyped blood cancer drug, ...

The Burberry turnaround is very much in its opening chapters, but the worst of the sales collapse may be in the rear-view mirror. The next big test will be whether fresh collections can tempt shoppers ...

Gold rebounds as dollar eases but remains on course for weekly loss after strong US data. Gold (XAU/USD) prices rose on Friday, clawing back some of the previous session’s losses as the dollar ...

GSK was the standout laggard on the FTSE 100, sinking 6.2% after a US Food & Drug Administration advisory panel voted against approving its cancer drug Blenrep at the proposed dosage. Although the FDA ...